CHU Amiens Picardie
Amiens, Picardie, 80054, France
Location status: Recruiting
NCT Number: NCT06318780
Among patients who have undergone EVAR, there is a significant risk of 20-50% endoleak. These endoleaks often require secondary interventions to reduce the risk of expansion or rupture. Currently, three-phase CT angiography and CEUS ultrasound are recommended in the post-operative monitoring of EVAR but these remain limited in characterizing the type and source of endoleak. In this study the investigators will study the interest of d-CTA for a better detection and characterization of endoleaks.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Amiens, Picardie, 80054, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
three-phase CT angiography
CEUS ultrasound
Time frame: 5 years
Endoleak classification using the CT angiography
Time frame: 5 years
Variation of Endoleak classification between CEUS ultrasound and the CT angiography
Contact information is provided by the study sponsor or research team.
Gabriel IFERGAN, Dr
CONTACT
Thierry REIX, Pr
CONTACT
Centre Hospitalier Universitaire, Amiens
Other
Acronym: LEAKDYN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07078383
Acute Aortic Syndrome, Aneurysm
Los Angeles, California, United States
View Trial DetailsNCT07662317
Aortic Diseases, Arterial Occlusive Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT07322913
Aortic Diseases, Arterial Occlusive Diseases
Hershey, Pennsylvania, United States
View Trial DetailsNCT07479186
Aortic Diseases, Cardiovascular Diseases
Roma, RM, Italy
View Trial Details